Is Pine Bark Extract Blood Pressure Randomized Trial safe?

Updated October 2026

Quick Answer

Pine Bark Extract Blood Pressure Randomized Trial has evidence relevant to safety, limits, and clinician-discussion contexts, but conclusions should stay close to the cited sources. One representative finding is: Several factors contribute to CMS-associated complications, including genetics, nutrition, epigenetics, lifestyle choices, and environmental factors [,].

Key Takeaways

  • 01Several factors contribute to CMS-associated complications, including genetics, nutrition, epigenetics, lifestyle choices, and environmental factors [,]. [Mohammadi Shooka (2025)]
  • 0211 12 11 13 14 11 15 12 16 17 Various pathological procedures are associated with diverse clinical manifestations of CMS [,]. [Mohammadi Shooka (2025)]
  • 03In addition, CMS is associated with increased OS and inflammatory marker levels []. [Mohammadi Shooka (2025)]
  • 041 2 3 4 5 6 7 9 7 10 Cardiometabolic syndrome (CMS), also known as metabolic syndrome (MetS) or insulin resistance syndrome, includes several metabolic dysfunctions []. [Mohammadi Shooka (2025)]
The current Migaku evidence database contains 2 reusable source documents for Pine Bark Extract Blood Pressure Randomized Trial. This answer focuses on safety, limits, and clinician-discussion contexts. - Several factors contribute to CMS-associated complications, including genetics, nutrition, epigenetics, lifestyle choices, and environmental factors [,]. [Mohammadi Shooka (2025); evidence level 1] - 11 12 11 13 14 11 15 12 16 17 Various pathological procedures are associated with diverse clinical manifestations of CMS [,]. [Mohammadi Shooka (2025); evidence level 1] - In addition, CMS is associated with increased OS and inflammatory marker levels []. [Mohammadi Shooka (2025); evidence level 1] - 1 2 3 4 5 6 7 9 7 10 Cardiometabolic syndrome (CMS), also known as metabolic syndrome (MetS) or insulin resistance syndrome, includes several metabolic dysfunctions []. [Mohammadi Shooka (2025); evidence level 1] - et Zucc.) bark is a by-product of the wood industry and contains a high level of antioxidative phenolics including flavonoids, which have a variety of beneficial health effects. [Kim KJ (2020); evidence level 4] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.

Sources

  1. Does supplementation with pine bark extract improve cardiometabolic risk factors? A systematic review and meta-analysis
  2. Antihypertensive Effects of Polyphenolic Extract from Korean Red Pine (<i>Pinus densiflora</i> Sieb. et Zucc.) Bark in Spontaneously Hypertensive Rats.